Brief: Rigel Reports Fourth Quarter And Full Year 2022 Financial Results

Rigel Pharmaceuticals

07/03/2023 21:02

March 7 (Reuters) - Rigel Pharmaceuticals Inc  RIGL.O :
    * RIGEL REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q4 EARNINGS PER SHARE $0.01
    * FOR Q4 OF 2022, TOTAL REVENUES WERE $51.3 MILLION
    * AS OF DECEMBER 31, 2022, RIGEL HAD CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENTS OF $58.2 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.11, REVENUE VIEW $28.0
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nPnqwb2ja 
Further company coverage:  RIGL.O 

 ((Reuters.Briefs@thomsonreuters.com;))